首页> 美国卫生研究院文献>Journal for Immunotherapy of Cancer >Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

【2h】

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

机译：在患有癌症患者的≥2级免疫相关不良事件中停止后免疫检查点抑制剂的安全性重新检查

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Safety of rechallenge of immune checkpoint inhibitor (ICI) after grade ≥2 immune-related adverse events (irAEs) leading to ICI discontinuation remains unclear.

机译：在≥2级免疫相关不良事件（IRAE）导致ICI停止后，免疫检查点抑制剂（ICI）的重新检查安全性仍不清楚。

著录项

期刊名称 Journal for Immunotherapy of Cancer
作者
Marion Allouchery; Thomas Lombard; Mickael Martin; Franck Rouby; Marion Sassier; Celia Bertin; Marina Atzenhoffer; Ghada Miremont-Salame; Marie-Christine Perault-Pochat; Mathieu Puyade;
展开▼
作者单位

展开▼
年(卷),期 2020(8),2
年度 2020
页码 e001622
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：免疫疗法;自身免疫;

相似文献

外文文献
中文文献
专利

1. Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer [J] . Marion Allouchery, Thomas Lombard, Mickael Martin, Journal for ImmunoTherapy of Cancer . 2020,第2期

机译：在患有癌症患者的≥2级免疫相关不良事件中停止后，免疫检查点抑制剂的安全性重新检查
2. Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy [J] . John Haanen, Marc Ernstoff, Yinghong Wang, Journal for ImmunoTherapy of Cancer . 2020,第1期

机译：重新检查严重免疫相关不良事件后免疫检查点抑制剂的患者：审查文献和建议的预防策略
3. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events [J] . Busra Isik, Mariam P. Alexander, Sandhya Manohar, Kidney International Reports . 2021,第4期

机译：生物标志物，临床特征和免疫检查点抑制剂肾免疫相关不良事件的重新检查
4. Identification of Patients with Immune-related Adverse Events from Clinical Notes using Machine Learning [C] . Samir Gupta, Anas Belouali, Neil Shah, IEEE International Conference on Healthcare Informatics . 2020

机译：使用机器学习鉴定免疫相关不良事件的患者
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not? [O] . Heidar J. Albandar, Jacob Fuqua, Jasim M. Albandar, 2021

机译：免疫相关的不良事件（IRAE）在癌症免疫检查点抑制剂（ICI）和生存结果相关性：重新检查或不进行何处？
7. Correction: Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer [O] . 2021

机译：矫正：免疫检查点抑制剂的安全性在停止后再达到≥2级免疫相关不良事件后的患者

Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer

摘要

著录项

相似文献

相关主题

期刊订阅